{"id":"NCT03412747","sponsor":"UCB Biopharma SRL","briefTitle":"A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis","officialTitle":"A Phase 3, Multicenter, Randomized, Double-Blind Study With an Active-Controlled Initial Treatment Period Followed by a Dose-Blind Maintenance Treatment Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-01-26","primaryCompletion":"2019-02-07","completion":"2020-02-26","firstPosted":"2018-01-26","resultsPosted":"2022-03-02","lastUpdate":"2023-12-20"},"enrollment":478,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Plaque Psoriasis","Moderate to Severe Plaque Psoriasis"],"interventions":[{"type":"DRUG","name":"Bimekizumab","otherNames":["UCB4940"]},{"type":"DRUG","name":"Adalimumab","otherNames":["HumiraÂ®"]},{"type":"OTHER","name":"Placebo","otherNames":["PBO"]}],"arms":[{"label":"Bimekizumab Arm 1","type":"EXPERIMENTAL"},{"label":"Bimekizumab Arm 2","type":"EXPERIMENTAL"},{"label":"Adalimumab Arm","type":"ACTIVE_COMPARATOR"}],"summary":"This is a study to compare the efficacy of bimekizumab versus adalimumab in the treatment of subjects with moderate to severe chronic plaque psoriasis (PSO).","primaryOutcome":{"measure":"Percentage of Participants With a Psoriasis Area and Severity Index 90 (PASI90) Response at Week 16","timeFrame":"Week 16","effectByArm":[{"arm":"Bimekizumab 320 mg Q4W + Bimekizumab 320 mg Q4W/Q8W (RS)","deltaMin":86.2,"sd":null},{"arm":"Adalimumab (RS)","deltaMin":47.2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":9},"locations":{"siteCount":77,"countries":["United States","Australia","Canada","Germany","Hungary","Poland","Russia","South Korea","Taiwan"]},"refs":{"pmids":["35544084","36689515","37950894","40886218","39578348","36751950","33891379"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":161},"commonTop":["Nasopharyngitis","Oral candidiasis","Upper respiratory tract infection","Hypertension","Diarrhoea"]}}